These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 37479090)

  • 21. Distinct Fastigial Output Channels and Their Impact on Temporal Lobe Seizures.
    Streng ML; Tetzlaff MR; Krook-Magnuson E
    J Neurosci; 2021 Dec; 41(49):10091-10107. PubMed ID: 34716233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optogenetic activation of septal inhibitory cells abates focal seizures.
    Lévesque M; Wang S; Etter G; Williams S; Avoli M
    J Neurophysiol; 2023 May; 129(5):1218-1223. PubMed ID: 37073973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in cellular optogenetics for photomedicine.
    Chen B; Cui M; Wang Y; Shi P; Wang H; Wang F
    Adv Drug Deliv Rev; 2022 Sep; 188():114457. PubMed ID: 35843507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How might novel technologies such as optogenetics lead to better treatments in epilepsy?
    Krook-Magnuson E; Ledri M; Soltesz I; Kokaia M
    Adv Exp Med Biol; 2014; 813():319-36. PubMed ID: 25012388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optogenetic and chemogenetic therapies for epilepsy.
    Walker MC; Kullmann DM
    Neuropharmacology; 2020 May; 168():107751. PubMed ID: 31494141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seizure suppression by high frequency optogenetic stimulation using in vitro and in vivo animal models of epilepsy.
    Chiang CC; Ladas TP; Gonzalez-Reyes LE; Durand DM
    Brain Stimul; 2014; 7(6):890-9. PubMed ID: 25108607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optogenetic cell control in experimental models of neurological disorders.
    Tønnesen J
    Behav Brain Res; 2013 Oct; 255():35-43. PubMed ID: 23871610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory or excitatory? Optogenetic interrogation of the functional roles of GABAergic interneurons in epileptogenesis.
    Ye H; Kaszuba S
    J Biomed Sci; 2017 Dec; 24(1):93. PubMed ID: 29202749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethics and regulation of neuronal optogenetics in the European Union.
    Faltus T; Freise J; Fluck C; Zillmann H
    Pflugers Arch; 2023 Dec; 475(12):1505-1517. PubMed ID: 37996706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac optogenetics: shining light on signaling pathways.
    Leemann S; Schneider-Warme F; Kleinlogel S
    Pflugers Arch; 2023 Dec; 475(12):1421-1437. PubMed ID: 38097805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GABAergic Interneurons in Seizures: Investigating Causality With Optogenetics.
    Magloire V; Mercier MS; Kullmann DM; Pavlov I
    Neuroscientist; 2019 Aug; 25(4):344-358. PubMed ID: 30317911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Light Up the Brain: The Application of Optogenetics in Cell-Type Specific Dissection of Mouse Brain Circuits.
    Lee C; Lavoie A; Liu J; Chen SX; Liu BH
    Front Neural Circuits; 2020; 14():18. PubMed ID: 32390806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamical Mechanism Analysis of Three Neuroregulatory Strategies on the Modulation of Seizures.
    Zhang H; Shen Z; Zhao Y; Du L; Deng Z
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On-demand optogenetic control of spontaneous seizures in temporal lobe epilepsy.
    Krook-Magnuson E; Armstrong C; Oijala M; Soltesz I
    Nat Commun; 2013; 4():1376. PubMed ID: 23340416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optical developments for optogenetics.
    Papagiakoumou E
    Biol Cell; 2013 Oct; 105(10):443-64. PubMed ID: 23782010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microbial Proteins as Novel Industrial Biotechnology Hosts to Treat Epilepsy.
    Amtul Z; Aziz AA
    Mol Neurobiol; 2017 Dec; 54(10):8211-8224. PubMed ID: 27905012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optogenetic control of astrocytes: is it possible to treat astrocyte-related epilepsy?
    Ji ZG; Wang H
    Brain Res Bull; 2015 Jan; 110():20-5. PubMed ID: 25451697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemically activated luminopsins allow optogenetic inhibition of distributed nodes in an epileptic network for non-invasive and multi-site suppression of seizure activity.
    Tung JK; Shiu FH; Ding K; Gross RE
    Neurobiol Dis; 2018 Jan; 109(Pt A):1-10. PubMed ID: 28923596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optogenetics in epilepsy.
    Bentley JN; Chestek C; Stacey WC; Patil PG
    Neurosurg Focus; 2013 Jun; 34(6):E4. PubMed ID: 23724838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beyond the hammer and the scalpel: selective circuit control for the epilepsies.
    Krook-Magnuson E; Soltesz I
    Nat Neurosci; 2015 Mar; 18(3):331-8. PubMed ID: 25710834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.